Endometriosis. Endometriosis
Conditions
Interventions
Intervention 1: The intervention group will receive oral vitamin D tablets with a dose of 4000 mg every other day for eight weeks, which will be prepared by Dana Pharmaceutical Company. Intervention 2
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Women who have endometriosis and it has been confirmed by laparoscopy. Women with symptomatic endometriosis. Women who are married and sexually active. Vitamin D serum level should be less than 30 ng/dl.
Exclusion criteria
Exclusion criteria: Patients with diabetes, thyroid disorders, high blood pressure, hyperprolactinemia and Cushing's syndrome Daily and regular consumption of supplements containing vitamin D during the last three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean score of painful symptoms of endometriosis. Timepoint: Before intervention and 8 weeks after the start of treatment. Method of measurement: Menstrual painful symptoms questionnaire (ENDOPAIN-4D). | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of lifemean score. Timepoint: Before intervention and 8 weeks after the start of treatment. Method of measurement: Endometriosis Health Profile-30.;Average severity of dysmenorrhea. Timepoint: Before intervention and 8 weeks after the start of treatment. Method of measurement: Visual Analog Scale.;The frequency of Gelofen consumption. Timepoint: During the treatment. Method of measurement: Checklist.;Adverse events. Timepoint: During the treatment. Method of measurement: Checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMojgan Mirghafourvand
Tabriz University of Medical Sciences
Outcome results
None listed